Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness

Cell & Gene: The Podcast by Erin Harris

Feb 12, 202614:20Science & Medicine

We love to hear from our listeners. Send us a message. In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS Therapies, to learn the company’s mission to address the severe unmet n...

Related Episodes

Continue listening to more episodes from Cell & Gene: The Podcast.

Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.

Sep 10, 2026 - 18:47

We love to hear from our listeners. Send us a message. In episode 137 of Cell & Gene: The Podcast, Host E...

Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous

Aug 27, 2026 - 40:25

We love to hear from our listeners. Send us a message. On episode 136 of Cell & Gene: The Podcast, Host E...

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Aug 13, 2026 - 16:18

We love to hear from our listeners. Send us a message. In Episode 135 of Cell & Gene: The Podcast, Host E...

Rewriting the Playbook for Stargardt Disease with Atsena Therapeutics' Shannon Boye, Ph.D.

Jul 30, 2026 - 18:05

We love to hear from our listeners. Send us a message. Episode 134 of Cell & Gene: The Podcast features H...

How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

Jul 16, 2026 - 18:03

We love to hear from our listeners. Send us a message. Episode 133 of Cell & Gene: The Podcast features H...

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

Jul 2, 2026 - 22:57

We love to hear from our listeners. Send us a message. Episode 132 of Cell & Gene: The Podcast features H...

Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Jun 18, 2026 - 85:47

We love to hear from our listeners. Send us a message. For episode 131 of Cell & Gene: The Podcast, we’re...

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Jun 12, 2026 - 18:11

We love to hear from our listeners. Send us a message. In Episode 3 of our in vivo-focused special series...